Clinical OMICs empowers healthcare professionals to harness the application of molecular-based
technologies to transform patient care through a combination of news, contributed articles, and expert analysis.
New molecular diagnostic uses RNA to distinguish bacterial infections from other causes of fever in infants up to two months old.
Increased use of biochips for genomic and proteomic applications in both the U.S. and Asian markets is expected to drive growth.
The research facility's goal is to revolutionize pathology practice via the application of advance computer science, microscopy and AI.
We will explore how liquid biopsies are shaping the diagnostic landscape and how it will impact physician decision making and patient care.
2015 was a phenomenal year full of new developments for the structures and mechanisms of CRISPR systems.